https://www.nxtpsychedelics.com/news/articles/public-companies/pharmather-enters-into-exclusive-option-agreement-with-case-western-reserve-university-to-develop-and-commercialize-ketamine-for-rett-syndrome/
PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University to Develop and Commercialize Ketamine for Rett Syndrome